ArticleJournal of Alzheimer's disease : JAD2016

AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics.

Susanna Eketjäll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.